In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 33 | Yes |
Popular Name: Rosuvastatin Calcium Rosuvastatin Calcium
Find On: PubMed — Wikipedia — Google
CAS Numbers: 147098-18-8 , 147098-20-2 , 287714-14-4, 147098-20-2(Ca salt) , 287714-41-4 , [147098-20-2]
147098-20-2; Crestor (TN); D01915; Rosuvastatin calcium (JAN/USAN); ZD 4522
287714-41-4; Creston (TN); D08492; Rosuvastatin (INN)
CPD000469281; ROSUVASTATIN Ca; SAM001246543
CPD000469281; SAM001246543; rosuvastatin calcium
INN); Rosuvastatin Calcium (FDA
Rosuvastatin calcium (Crestor)
Rosuvastatin hemicalcium; ZD 4522
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.11 | 8.5 | -58.63 | 2 | 9 | -1 | 144 | 480.538 | 10 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 8.86e-02 g/l | DrugBank-approved |
biological_use | Antihypercholesterolemic | IBScreen Bioactives ZereneX Building Blocks |
Therapy | antihyperlipidemic | SMDC MicroSource |
Patent Database Links | EP1325745; EP1510208; EP1541175; EP1563837; EP1589115; EP1614429; EP1618893; EP1621210; EP1695706; EP1719768; EP1731147; EP1745781; EP1752145; EP1782804; EP1803440; EP1816126; EP1832576; EP1864680; EP1884513; EP1894576; EP1905424; EP1911462; EP1923060; EP | ChEBI |
Target | HMG-CoA Reductase | Selleck Chemicals |
mechanism | Hypolipidaemic HMG-CoA reductase inhibitor | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP013265r | NIH Clinical Collection via PubChem |
biological_use | preventing cardiovascular diseases | IBScreen Bioactives |
Target | RAAS | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP013265r | NIH Clinical Collection via PubChem |
PUBCHEM_PATENT_ID | WO2000042024A1; WO2000045817A1; WO2000045818A1; WO2000045819A1; WO2000049014A1 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HMDH-2-E | HMG-CoA Reductase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4 | 0.36 | Binding ≤ 10μM |
HMDH-2-E | HMG-CoA Reductase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 9030 | 0.21 | Binding ≤ 10μM |
Z102178-1-O | Liver Microsomes (cluster #1 Of 2), Other | Other | 4 | 0.36 | Functional ≤ 10μM |
Z81135-2-O | L6 (Skeletal Muscle Myoblast Cells) (cluster #2 Of 4), Other | Other | 720 | 0.26 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HMDH_RAT | P51639 | HMG-CoA Reductase, Rat | 2.1 | 0.37 | Binding ≤ 1μM |
HMDH_HUMAN | P04035 | HMG-CoA Reductase, Human | 0.9 | 0.38 | Binding ≤ 1μM |
HMDH_RAT | P51639 | HMG-CoA Reductase, Rat | 2.1 | 0.37 | Binding ≤ 10μM |
HMDH_HUMAN | P04035 | HMG-CoA Reductase, Human | 0.9 | 0.38 | Binding ≤ 10μM |
Z81135 | Z81135 | L6 (Skeletal Muscle Myoblast Cells) | 210 | 0.28 | Functional ≤ 10μM |
Z102178 | Z102178 | Liver Microsomes | 3.6 | 0.36 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of gene expression by SREBF (SREBP) | |
Cholesterol biosynthesis | |
PPARA activates gene expression |